264 related articles for article (PubMed ID: 16857924)
1. Science and government. Enhanced: in defense of NCCAM.
Straus SE; Chesney MA
Science; 2006 Jul; 313(5785):303-4. PubMed ID: 16857924
[No Abstract] [Full Text] [Related]
2. Science and government. Review for NCCAM is overdue.
Marcus DM; Grollman AP
Science; 2006 Jul; 313(5785):301-2. PubMed ID: 16857923
[No Abstract] [Full Text] [Related]
3. Biomedical research. A low-stress scheme for overhauling NIH's structure.
Kaiser J
Science; 2003 Aug; 301(5633):574-5. PubMed ID: 12893911
[No Abstract] [Full Text] [Related]
4. National Institutes of Health. Two strikes and you're out, grant applicants learn.
Kaiser J
Science; 2008 Oct; 322(5900):358. PubMed ID: 18927363
[No Abstract] [Full Text] [Related]
5. U.S. science budget. Advocates win 'exceptional' boost for Alzheimer's research.
Kaiser J
Science; 2012 Feb; 335(6071):902. PubMed ID: 22362980
[No Abstract] [Full Text] [Related]
6. The National Institutes of Health investment in research on botanicals.
Coates PM; Meyers CM
Fitoterapia; 2011 Jan; 82(1):11-3. PubMed ID: 21075178
[TBL] [Abstract][Full Text] [Related]
7. Debating the Worth of NCCAM Research.
Folkman S; Berman B; Bondurant S; Eisenberg D; Haramati A; Kreitzer MJ; Kronenberg F
Science; 2006 Nov; 314(5802):1083-4; author reply 1083-4. PubMed ID: 17110556
[No Abstract] [Full Text] [Related]
8. Research funding. Politics and funding in the U.S. public biomedical R&D system.
Hegde D; Mowery DC
Science; 2008 Dec; 322(5909):1797-8. PubMed ID: 19095928
[No Abstract] [Full Text] [Related]
9. U.S. science policy. Risky business.
Mervis J
Science; 2004 Oct; 306(5694):220-1. PubMed ID: 15472055
[No Abstract] [Full Text] [Related]
10. Recombinant DNA Advisory Committee: minutes of meeting, 14 Jan 1993.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1993 Aug; 4(4):529-44. PubMed ID: 11643161
[No Abstract] [Full Text] [Related]
11. Biomedical policy. Shrugging off doubters, NIH launches a new institute.
Kaiser J
Science; 2003 Jan; 299(5604):193-4. PubMed ID: 12522231
[No Abstract] [Full Text] [Related]
12. The use of complementary and alternative therapies.
Corless IB; Abrams D; Nicholas PK; McGibbon CA
AACN Clin Issues; 2000 Feb; 11(1):4-6. PubMed ID: 11040547
[TBL] [Abstract][Full Text] [Related]
13. The NCCAM and new research priorities.
Parkman CA
Case Manager; 2004; 15(2):28-32. PubMed ID: 15026765
[No Abstract] [Full Text] [Related]
14. Supporting the Next Generation of Biomedical Researchers.
Daniels R; Dzau V
JAMA; 2018 Jul; 320(1):29-30. PubMed ID: 29902324
[No Abstract] [Full Text] [Related]
15. Advocacy for basic biomedical research.
Silverstein SC
FASEB J; 1995 Feb; 9(2):160-1. PubMed ID: 7781917
[No Abstract] [Full Text] [Related]
16. Science and government. HHS intervenes in choice of study section members.
Ferber D
Science; 2002 Nov; 298(5597):1323. PubMed ID: 12434032
[No Abstract] [Full Text] [Related]
17. Biomedical research. Panel hears ideas for overhaul of NIH.
Kaiser J
Science; 2002 Aug; 297(5583):917-9. PubMed ID: 12169704
[No Abstract] [Full Text] [Related]
18. The quality of mercy.
Crigger BJ
Hastings Cent Rep; 1993; 23(3):3. PubMed ID: 11643129
[No Abstract] [Full Text] [Related]
19. Varmus orders up a review of the science of gene therapy.
Marshall E
Science; 1995 Mar; 267(5204):1588. PubMed ID: 7886441
[No Abstract] [Full Text] [Related]
20. The complementary and alternative medicine controversy continues: the IOM report.
Lipman AG
J Pain Palliat Care Pharmacother; 2005; 19(4):5-9. PubMed ID: 16431827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
